SRP384561 PRJNA854948 GSE207375 PolyA RNA-seq from retinoic acid-differentiated iPSCs treated with GSK343, 5-aza, or Combo (GSK343 & 5-aza) Analysis of steady-state mRNA levels in induced pluripotent stem cells (iPSCs) differentiated for 5 days with retinoic acid (RA) and treated for final 48 hrs with GSK343 (EZH2 inhibitor), 5-azacytidine (5-aza, DNA methyltransferase inhibitor), or their combination (Combo). Overall design: Two independent biological replicates each of RA-differentiated iPSCs treated with 4µM GSK343, 5µM 5-azacytidine (5-aza), or Combo (4µMGSK343 & 5µM 5-aza). GSE207375 pubmed 36681780 parent_bioproject PRJNA854943